New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
08:37 EDTCPHDCepheid upgraded at Needham
As previously reported, Needham upgraded Cepheid to Buy from Hold. The firm upgraded shares based on expectations for faster growth driven by recent international launches of HPV and Norovirus, virology expansion, and U.S. sales management changes that should driver faster growth. Price target is $50.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
09:26 EDTCPHDCepheid price target raised to $67 from $58 at JMP Securities
Subscribe for More Information
April 23, 2015
16:27 EDTCPHDCepheid sees FY15 adjusted EPS 25c-29c, may not compare to consensus (52c)
Subscribe for More Information
16:26 EDTCPHDCepheid reports Q1 adjusted EPS 17c, may not compare to consensus (16c)
Subscribe for More Information
April 16, 2015
07:06 EDTCPHDCepheid's Xpert HIV-1 Qual for HIV approved in Europe
Subscribe for More Information
April 15, 2015
07:02 EDTCPHDCepheid announces European approval of Xpert HCV Viral Load
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use